
Pioneering AI Drug Discovery | Recursion
All of our results feed back into our drug discovery and drug development platform – the Recursion Operating System – in a continuously improving feedback loop.
Recursion's Drug Discovery Pipeline | Recursion
Leveraging the power of the Recursion OS, we are building an industry-leading pipeline of potential best-in-class and first-in-class therapeutic assets. We focus on indications with high unmet need, …
Recursion OS:
By leveraging Recursion’s vast data universe and machine learning models at every stage of the discovery, design and delivery process, we are able to rapidly validate and accelerate high-potential …
Recursion Pharmaceuticals, Inc. - MIT and Recursion Release Boltz-2 ...
Jun 6, 2025 · Powered by Recursion's NVIDIA supercomputer for its training and validation, this next-generation AI model achieves best-in-class accuracy in jointly modeling complex structures and …
Recursion Pharmaceuticals, Inc. - Recursion and Exscientia, two leaders ...
Nov 20, 2024 · “I believe the combination of the incredible teams and platforms at Exscientia and Recursion position us as the leader of the AI-enabled drug discovery and development space,” said …
How a First-of-its-Kind “Microglia Map” from Recursion and Roche and ...
Oct 29, 2025 · A first-of-its-kind whole genome map from researchers at Recursion with partners Roche and Genentech offers a new approach to exploring novel targets and pathways for a wide range of …
Recursion Reports Third Quarter 2025 Financial Results and Provides ...
Oct 9, 2025 · Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Montréal, New York, London, …
From Novel Discovery to Precision Biomarkers: How Recursion is Using ...
Aug 12, 2025 · Recursion is actively leveraging the power of its AI-driven phenomics platform – along with other forms of data, including genetic and real world patient data – to discover new ways to …
Recursion Pharmaceuticals, Inc. - Recursion and Exscientia Enter ...
Aug 8, 2024 · Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Toronto, Montreal, the San …
Recursion Pharmaceuticals, Inc. - Recursion announces first patient ...
Dec 3, 2024 · Recursion identified the novel regulatory role of RBM39 on CDK12 function using its AI-powered maps of biology. Recursion believes the modulation of RBM39 may be associated with a …